Brandon (Host)
speaker
390 appearances
3 recordings
1 series
first heard Jun 2026
last heard 16 Jul
Brandon (Host)’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 3 in all, peaking in Jul 2026 with 2.
Appearances
Just a business question here.
What is the space of things which are the target is the biology is understood, the structure is understood, right?
and that, you know, the only thing you really needed to do is find the right lock, that seems like you probably would have already picked over that class of targets.
In some sense, those are easy targets, right?
So how much opportunity is there for that?
So there's two orthogonal concepts.
Do they anti-correlate or is it just that we have picked all the low-hanging fruit, which do solve both things?
OK.
Yeah.
So we so far have talked about genesis modeling in terms of, let's say, this one specific problem of protein ligand binding.
How does your overall world work in terms of developing this?
I mean, I assume that you must.
I mean, I do know that you have other things that you've worked on in solving the broader early phase drug discovery problem.
The broader community, like protein folding community and drug discovery community immediately said there's other things you care about, like dynamics, like just a single static structure is not enough to understand what's going on, interactions.
Yeah, so there's lots of things there in addition to just like having a static structure.
I think many people thought those were very useful, like they've really accelerated science, but it was very clearly a starting point and not an end condition.
Otherwise, like, there's an entire ML structure biology community, which will all just jump on us and say, like, no, no, not a solid problem.
Gotta throw those caveats in.
Absolutely not a solid problem.
The worst part is that
Showing 181–200 of 390 · page 10 of 20
← Previous
Next →